Maurice P.H.M. Jansen

3.1k citations

66 papers · 2.2k indexed · h-index 26

Cancer Research top 1%
- Cancer Genomics and Diagnostics 33
Oncology top 5%
- Cancer Cells and Metastasis 8
- HER2/EGFR in Cancer Research 5
Molecular Biology top 5%
- Single-cell and spatial transcriptomics 8
- PI3K/AKT/mTOR signaling in cancer 6
Pathology and Forensic Medicine top 5%
- Genetic factors in colorectal cancer 12
Reproductive Medicine top 5%
Genetics
- Estrogen and related hormone effects 13
Pulmonary and Respiratory Medicine
- Renal cell carcinoma treatment 6

Co-authors: Els M.J.J. Berns John A. Foekens Maxime P. Look Stefan Sleijfer Iris L. van Staveren Marion E. Meijer‐van Gelder Anieta M. Sieuwerts Jozien Helleman
Cited by: Cancer Research Oncology Molecular Biology
Journals: Molecular Oncology (9 papers)Breast Cancer Research and Treatment (5 papers)The Journal of Pathology (4 papers)
Partner nations: Netherlands Italy Belgium

In The Last Decade

Maurice P.H.M. Jansen

62 papers receiving 2.2k citations

Peers

Countries citing papers authored by Maurice P.H.M. Jansen

Since Specialization

Citations

This map shows the geographic impact of Maurice P.H.M. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice P.H.M. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice P.H.M. Jansen more than expected).

Fields of papers citing papers by Maurice P.H.M. Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice P.H.M. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice P.H.M. Jansen. The network helps show where Maurice P.H.M. Jansen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maurice P.H.M. Jansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maurice P.H.M. Jansen Line = papers co-authored together Maurice P.H.M. Jansen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genome-wide cell-free DNA methylation profiling in advanced stage ovarian cancer. Are we looking at the tumor or the patient's immune response to the tumor? Cancer Treatment and Research Communications ·Angela M Sihotang,Ika Kurnia S,Ingrid Boere,Ruben Boers,Joachim Boers,Wilfred F. J. van IJcken,Maurice P.H.M. Jansen,H. Li,Joost Gribnau,Heleen J. van Beekhuizen	2025	0
2	Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer Cell Death and Differentiation ·Tong Xu,Yaxu Hu,Miriam Teeuwssen,Wenjie Sun,Rosalie Joosten,Andrea Sacchetti,Patricia C. Ewing‐Graham,Maurice P.H.M. Jansen,Ingrid Boere,Nicole S. Bryce,Jun Zeng,Herbert Treutlein,Jeff Hook,Edna C. Hardeman,Peter W. Gunning,Riccardo Fodde	2024	5
3	Circulating tumor cells and tumor DNA in patients with resectable colorectal liver metastases: The MIRACLE. Journal of Clinical Oncology ·譲二棚田,Maurice P.H.M. Jansen,Jaco Kraan,Corine M. Beaufort,伸司鈴木,Eric J.T. Belt,Maarten Vermaas,Paul D. Gobardhan,Stefan Sleijfer,Henk M.W. Verheul,Saskia M. Wilting,Dirk J. Grünhagen,John W.M. Martens,Cornelis Verhoef	2024	1
4	Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients Genes ·H. Li,Angela M Sihotang,Ruben Boers,Jean Helmijr,于阳,نعیم‌الدین متاجی کجوری,Katia D. Rivero-Angeles,Corine M. Beaufort,Jaco Kraan,Wilfred F. J. van IJcken,Joost Gribnau,A. Rzasa,Melike Saraç,C Harnett,Heleen J. van Beekhuizen,Tuba Günel,Saskia M. Wilting,John W.M. Martens,Maurice P.H.M. Jansen,Ingrid Boere	2024	4
5	External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium Clinical Chemistry ·Paul van der Leest,Jier Yang,John W. J. Hinrichs,Carel J.M. van Noesel,Karen Zwaenepoel,Birgit Deiman,Brianna M. Wong,Ronald van Eijk,Ernst‐Jan M. Speel,Lanna Jin,Marjolijn J. L. Ligtenberg,E. Cosci,Maurice P.H.M. Jansen,Hendrikus J. Dubbink,Andrea Monaldini,Mathie P.G. Leers,Menno Tamminga,Daan van den Broek,Léon C.L.T. van Kempen,Ed Schuuring	2024	1
6	Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels Scientific Reports ·Elisabeth M. Jongbloed,Maurice P.H.M. Jansen,Vanja de Weerd,Elizaveta V. Kotova,Corine M. Beaufort,Marcel Reinders,Ronald van Marion,Wilfred F. J. van IJcken,Gabe S. Sonke,Inge R. Konings,Agnes Jager,John W.M. Martens,Saskia M. Wilting,于阳	2023	2
7	Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer The Journal of Pathology ·Ben M. Eyck,Maurice P.H.M. Jansen,Bo Jan Noordman,Peggy N. Atmodimedjo,Berend J. van der Wilk,John W.M. Martens,Elizaveta V. Kotova,Corine M. Beaufort,Bianca Mostert,Michail Doukas,Bas P. L. Wijnhoven,Sjoerd M. Lagarde,J. Jan B. van Lanschot,Winand N.M. Dinjens	2022	9
8	The COMPLETE trial: HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study BMJ Open ·Gerda M. Verduijn,Maria Figuera,Yuan‐Wei Ma,H S Maiti,Juan A. Hernández‐Tamames,Wilma D. Heemsbergen,Aniel Sewnaik,José A. Hardillo,Hetty Mast,Yvette van Norden,Maurice P.H.M. Jansen,Aad van der Lugt,Dik C. van Gent,Mischa S. Hoogeman,Bianca Mostert,Steven Petit	2022	1
9	Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling Clinical Chemistry ·Paul van der Leest,В А Илясов,Carel J.M. van Noesel,Daan van den Broek,Jon-Atle Larsen,Birgit Deiman,George O'Dell Frie,Robert van der Geize,Brianna M. Wong,Ernst‐Jan M. Speel,Maartje J. Geerlings,E. Cosci,Maurice P.H.M. Jansen,مبارك عبدالقادر,Else Driehuis,Mathie P.G. Leers,Grigory Sidorenkov,Menno Tamminga,Léon C.L.T. van Kempen,Ed Schuuring	2022	18
10	High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms Molecular Oncology ·Lisanne F. van Dessel,Silvia Rita Vitale,Jean Helmijr,Saskia M. Wilting,Michelle van der Vlugt‐Daane,Esther Oomen‐de Hoop,Stefan Sleijfer,John W.M. Martens,Maurice P.H.M. Jansen,Martijn P. Lolkema	2018	38
11	SNPitty Journal of Molecular Diagnostics ·Job van Riet,J. R. Bamberger,Peggy N. Atmodimedjo,Erwin Brosens,Wilfred F. J. van IJcken,Maurice P.H.M. Jansen,John W.M. Martens,Leendert H. J. Looijenga,Guido Jenster,Hendrikus J. Dubbink,Winand N.M. Dinjens,Harmen J.G. van de Werken	2018	13
12	Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNA Scientific Reports ·Marjolein J.A. Weerts,Ronald van Marion,Jean Helmijr,Corine M. Beaufort,J. R. Bamberger,Anita Trapman-Jansen,Winand N.M. Dinjens,Stefan Sleijfer,Maurice P.H.M. Jansen,John W.M. Martens	2017	6
13	Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis Translational Oncology ·Gabriele Sofía,Anne Timmermans,Elizaveta V. Kotova,John W.M. Martens,Els M.J.J. Berns,Maurice P.H.M. Jansen	2017	5
14	LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome Molecular Oncology ·Gabriele Sofía,Kirsten Ruigrok-Ritstier,Jean Helmijr,Maxime P. Look,吕续臣,Luc Dirix,Els M.J.J. Berns,Maurice P.H.M. Jansen	2016	29
15	Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases Molecular Oncology ·Nick Beije,Jean Helmijr,Marjolein J.A. Weerts,Corine M. Beaufort,Matthew Wiggin,Andre Marziali,Cornelis Verhoef,Stefan Sleijfer,Maurice P.H.M. Jansen,John W.M. Martens	2016	63
16	High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer Annals of Oncology ·I. AfonsoGomes,A. Mieke Timmermans,Maxime P. Look,Marion E. Meijer‐van Gelder,Özge Key Abdullayev,Carolien H. M. van Deurzen,John W.M. Martens,Stefan Sleijfer,John A. Foekens,P.M.J.J. Berns,Maurice P.H.M. Jansen	2014	46
17	Hallmarks of Aromatase Inhibitor Drug Resistance Revealed by Epigenetic Profiling in Breast Cancer Cancer Research ·Maurice P.H.M. Jansen,Theo Knijnenburg,I. AfonsoGomes,Iris Simón,Ron Kerkhoven,Marjolein Droog,Arno Velds,Steven Van Laere,Luc Dirix,Xanthippi Alexi,John A. Foekens,Lodewyk F.A. Wessels,Sabine C. Linn,Els M.J.J. Berns,Wilbert Zwart	2013	57
18	Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen Breast Cancer Research and Treatment ·Gabriele Sofía,Jean Helmijr,Maxime P. Look,Irene Lurkin,Kirsten Ruigrok-Ritstier,Steven Van Laere,Luc Dirix,Fred C.G.J. Sweep,Paul N. Span,Sabine C. Linn,John A. Foekens,Stefan Sleijfer,Els M.J.J. Berns,Maurice P.H.M. Jansen	2013	43
19	Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response Clinical Cancer Research ·Jozien Helleman,Maurice P.H.M. Jansen,Kirsten Ruigrok-Ritstier,Iris L. van Staveren,Maxime P. Look,Marion E. Meijer‐van Gelder,Anieta M. Sieuwerts,Jan G.M. Klijn,Stefan Sleijfer,John A. Foekens,Els M.J.J. Berns	2008	142
20	Serum proteomic patterns for ovarian cancer monitoring International Journal of Gynecological Cancer ·Jozien Helleman,Meral Arca,Maurice P.H.M. Jansen,Theo M. Luider,M.E.L. van der Burg,G. Stoter,E. Berns	2007	19

About Maurice P.H.M. Jansen

Maurice P.H.M. Jansen is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 66 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (33 papers), Estrogen and related hormone effects (13 papers), Genetic factors in colorectal cancer (12 papers), Single-cell and spatial transcriptomics (8 papers), Cancer Cells and Metastasis (8 papers), Renal cell carcinoma treatment (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (806 citations) and Molecular Biology (1.3k citations). Maurice P.H.M. Jansen has collaborated with scholars based in Netherlands, Italy and Belgium. Frequent co-authors include Els M.J.J. Berns, John A. Foekens, Maxime P. Look, Stefan Sleijfer, Iris L. van Staveren, Marion E. Meijer‐van Gelder, Anieta M. Sieuwerts, Jozien Helleman, Jan G.M. Klijn and John W.M. Martens. Their work appears in journals such as Molecular Oncology, Breast Cancer Research and Treatment, The Journal of Pathology, Cancer Research and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact